Hims vs Ro: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Hims beats Ro overall, scoring 7.9/10 vs 7.2/10. Hims is more affordable at $175/mo vs $344/mo. Choose Hims for men who want glp-1 access from a well-known, publicly traded. Choose Ro for users with insurance who want brand-name medications from a .
A side-by-side comparison of Hims and Ro covering pricing, scores, medication types, insurance, and more to help you decide.
Hims
#12 of 40One of the largest and most recognized men's telehealth platforms in the US, offering compounded GLP-1 medications with a polished app experience and strong brand trust.
Visit HimsRo
#36 of 40One of the most recognized telehealth brands offering brand-name GLP-1 medications with insurance support and a streamlined process.
Visit Ro| Feature | Hims | Ro |
|---|---|---|
| Our Score | 7.9/10 | 7.2/10 |
| Starting Price | $175/mo | $344/mo |
| Medication Type | Compounded | Brand |
| Insurance Accepted | No | Yes |
| Best For | Men who want GLP-1 access from a well-known, publicly traded telehealth brand | Users with insurance who want brand-name medications from a trusted platform |
| Ranking | #12 | #36 |
Pros & Cons Compared
Hims
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Polished app and web experience — one of the best user interfaces in men's telehealth
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Massive brand recognition and extensive customer support infrastructure
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through the platform
- −Generic support experience — large patient volume means less personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
Ro
Pros
- +The most recognized telehealth brand in GLP-1s — operating since 2017 with millions of patients served
- +Direct insurance billing with major carriers — with coverage, Wegovy or Zepbound can cost $0-25/mo copay
- +$99/mo self-pay starting price for brand-name medications, among the lowest for FDA-approved drugs
- +Same-day prescriptions common — streamlined intake means most patients get approved within hours
Cons
- −Brand-name only — no compounded semaglutide or tirzepatide, which means no cheaper generic alternatives
- −Without insurance, brand-name costs jump significantly ($299+/mo for Wegovy at higher doses)
Our Verdict
Hims edges out Ro with a score of 7.9/10 vs 7.2/10. If budget is your priority, Hims starts at $175/mo compared to Ro's $344/mo. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Hims if you want: men who want glp-1 access from a well-known, publicly traded telehealth brand. Choose Ro if you want: users with insurance who want brand-name medications from a trusted platform.